Capital International Investors
TERN

Capital International Investors’s Terns Pharmaceuticals TERN Stock Holding History

Capital International Investors’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.1M Buy
1,424,504
+364,504
+34% +$15M 0.02% 306
2025
Q4 		$42.8M Buy
+1,060,000
New +$24.5M 0.01% 362

Other funds holding TERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Capital International Investors's TERN Position: Q1 2026 in Review

Capital International Investors increased its Terns Pharmaceuticals (TERN) stake by 34% in Q1 2026, buying an estimated $15M and bringing the position to 1,424,504 shares worth $75.1M. The position accounts for 0.02% of the portfolio, ranked #306.

Capital International Investors first reported a position in TERN in Q4 2025 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Capital International Investors held 1,424,504 shares of Terns Pharmaceuticals worth $75.1M as of Q1 2026.
  • Capital International Investors bought 364,504 Terns Pharmaceuticals shares in Q1 2026, an estimated $15M.
  • Terns Pharmaceuticals made up 0.02% of Capital International Investors's portfolio in Q1 2026, its #306 holding.
  • Capital International Investors first reported a position in Terns Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.